

Clinician's Roundtable
ReachMD
Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.
Episodes
Mentioned books

Jul 3, 2008 • 0sec
Just Enough Anxiety: Successful Leadership
Host: Leslie P. Lundt, MD
Guest: Robert Rosen, PhD
Dr. Robert Rosen was awarded a six-year multi-million dollar grant from the John D. and Catherine T. MacArthur Foundation to study leadership and healthy organizations. Having interviewed more than 250 CEOs and worked with organizations in more than 30 countries, Dr. Rosen says anxiety is a necessary and desirable feature of a successful leader. He expands on this idea in a conversation about his latest book, Just Enough Anxiety, with host Dr. Leslie Lundt

Jul 2, 2008 • 0sec
deCode MI: Another Tool to Assess Patient's MI Risk
Guest: Jeffrey Gulcher, MD PhD
Host: Larry Kaskel, MD
Are we already able to assess our patients accurately for MI risk factors or is there another test that could provide more accuracy? Our guest today, Dr. Jeffrey Gulcher, chief scientific officer and co-founder of deCode Genetics tells host, Dr. Larry Kaskel about deCode MI. Learn how to use and interpret the results of the new decode MI test. What can you learn that you don't already know?

Jul 2, 2008 • 0sec
Managing the Unhappy Plastic Surgery Patient
Guest: Richard Goode, MD
Host: Larry Kaskel, MD
Are your patients' expectations too high? Could docs be at fault for setting those expectations? Dr. Richard Goode, professor of otolaryngology at Stanford University Medical Center, joins host Dr. Larry Kaskel to discuss his recent article, The Unhappy Patient Following Facial Plastic Surgery: What to Do? and analyze why some patients will always be dissatisfied with the results. Tune in to hear how to identify those unhappy patients before they undergo a procedure. Does surgeons have an ethical obligation to treat and/or refuse treatment to these patients?

Jul 2, 2008 • 0sec
Can a CME Course Help the Disruptive Physician?
Host: Bill Rutenberg, MD
Guest: Charles Samenow, MD, MPH
Disruptive Physicians: Do you work with one? Do you manage one? What can you do to help a disruptive or "distracted" physician? Our guest Dr. Charles Samenow, instructor in the Department of Psychiatry and Behavioral Sciences at the George Washington University School of Medicine and Health Sciences and co-author of a recent NEJM publication entitled, Disruptive Physician - A CME Course Aimed At Addressing Disruptive Physician Behaviorexplains a CME course aimed at training referred physicians. In this segment learn about the content, logistics, goals and successes of this life changing course. Hosted by Dr. Bill Rutenberg.

Jul 2, 2008 • 0sec
Confronting Disruptive Physician Behavior
Host: Bill Rutenberg, MD
Guest: Charles Samenow, MD, MPH
How do you define disruptive physician? They are not always the loud, intimidating, abusive physician but also the one unwilling to return phone calls timely or properly chart a case. Dr. Charles Samenow, psychiatrist in the Department of Psychiatry and Behavioral Sciences at George Washington University Medical Faculty Associates joins host Dr. Bill Rutenberg to discuss a recent paper he co-authored, Disruptive Physician - A CME Course Aimed At Addressing Disruptive Physician Behavior. Better communication programs and more teaching of self-awareness can help to decrease inappropriate behavior. We must also become a healthcare community that does not tolerate this type of behavior.

Jul 2, 2008 • 0sec
Finasteride Dilema: To Treat or Not To Treat?
Guest: Stewart Justman, PhD
Host: Maurice Pickard, MD
Professor Stewart Justman discusses his new book "Do No Harm" in which the results of finasteride trial that ended in 2003 are looked at again. By reducing the size of the gland, what previously had appeared to be causing increased aggressive cancers may now be called into question. We will have to decide whether a healthy man should take a treatment to prevent a disease he may never get and if he did might be better off in not going through treatment.

Jul 2, 2008 • 0sec
A Magic Bullet for Prostate Cancer or a Medical Quandary?
Host: Maurice Pickard, MD
Guest: Stewart Justman, PhD
Professor Stewart Justman discusses his new book "Do No Harm" in which the results of the Prostate Cancer Prevention Trial cause us to reflect on Hippocratic ethical principals of 300BCE in our present practice. Finasteride leaves us with an ambiguity of reducing the incidence of cancer but also associated with a higher rate of aggressive neoplasm. In chemoprevention is any risk too much to be expectable? Hosted by Maurie Pickard.

Jul 2, 2008 • 0sec
A Model for Processing Pharmaceutical Information
Host: Maurice Pickard, MD
Dr. William Galanter, assistant professor of pharmacy at University of Illinois College of Medicine, speaks to doctors about the real cost of drug industry lunches and samples. It is time that the government looks at comparative drug efficacy. Also physicians should not have to be confronted by pharmaceutical representatives who know their prescription data. Join Host Maurie Pickard.

Jul 2, 2008 • 0sec
Pharmaceutical Representatives are Not Going Away. How Can They Help Us Most?
Host: Maurice Pickard, MD
Dr. William Galanter, assistant professor of pharmacy at University of Illinois College of Medicine, discusses the ongoing relationship between physicians and drug representatives and how the 19 billion dollars that pharmaceutical companies spend on this "educational/marketing tool" can be used to provide the best and most cost effective care for our patients. Education institutions must teach young learners how to evaluate the literature that is not biased so that they are not overwhelmed by industrial pressures their first day in practice.

Jul 1, 2008 • 0sec
A Novel Migraine-Minimizing Device
Guest: Richard B. Lipton, MD
Host: Mark Nolan Hill, MD
For decades, researchers and medical professionals have pursued a more concrete understanding of migraine headaches. We're still not sure of the origin of migraines, but we may have found a device that minimizes their impact. Dr. Richard Lipton, professor and vice chair of neurology at Albert Einstein College of Medicine, and director of the Montefiore Headache Center in New York City, shares details on this device with host Dr. Mark Nolan Hill.